P1269: PRIMARY GRAFT FAILURE INCIDENCE, RISK FACTORS, AND OUTCOMES IN PATIENTS UNDERGOING NON-MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION USING POST-TRANSPLANT CYCLOPHOSPHAMIDE

• Jonaphine Mata,
• Natalie S. Rosen,
• Marianna Zahurak,
• Richard Jones,
• Alex Ambinder

Affiliations

Jonaphine Mata

1 Johns Hopkins Hospital, Internal Medicine, Baltimore, United States

Natalie S. Rosen

2 New York Presbyterian Hospital-Columbia: Cancer Center, New York, United States

Marianna Zahurak

3 The Johns Hopkins University School of Medicine, Division of Biostatistics and Bioinformatics, Baltimore, United States

Richard Jones

4 Johns Hopkins Hospital, Sidney Kimmel Cancer Center, Baltimore, United States

Alex Ambinder

4 Johns Hopkins Hospital, Sidney Kimmel Cancer Center, Baltimore, United States